Cogent Biosciences, Inc.
COGT
$11.40
-$0.02-0.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -43.62% | 8.04% | 20.24% | 10.27% | 97.83% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 17.20% | 85.64% | -13.06% | 31.93% | 29.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -42.77% | 9.49% | 19.44% | 10.60% | 95.30% |
|
|
|||||
| Total Current Assets | -42.77% | 9.49% | 19.44% | 10.60% | 95.30% |
| Net Property, Plant & Equipment | -11.22% | -12.45% | -10.51% | -9.98% | -8.73% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -0.04% | 0.00% | 1.82% | 1.82% |
| Total Assets | -40.39% | 4.61% | 8.04% | 9.57% | 80.89% |
|
|
|||||
| Total Accounts Payable | -9.07% | 12.75% | 52.62% | 25.33% | 273.08% |
| Total Accrued Expenses | 73.56% | 226.60% | 56.89% | 73.14% | 27.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.50% | 12.91% | 13.10% | 25.32% | 51.21% |
| Total Finance Division Other Current Liabilities | -23.90% | -15.42% | -33.19% | -49.19% | -37.34% |
| Total Other Current Liabilities | -23.90% | -15.42% | -33.19% | -49.19% | -37.34% |
| Total Current Liabilities | 34.43% | 45.96% | 52.79% | 55.31% | 73.70% |
|
|
|||||
| Total Current Liabilities | 34.43% | 45.96% | 52.79% | 55.31% | 73.70% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.43% | -8.96% | -8.53% | -8.11% | -7.69% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 20.50% | 28.72% | 31.99% | 29.06% | 35.68% |
|
|
|||||
| Common Stock & APIC | 20.87% | 25.41% | 25.55% | 25.65% | 41.10% |
| Retained Earnings | -40.71% | -42.39% | -44.11% | -45.97% | -47.17% |
| Treasury Stock & Other | 520.51% | 81.71% | 620.93% | -97.94% | -343.75% |
| Total Common Equity | -44.64% | -26.33% | -15.98% | -9.44% | 24.14% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -51.31% | 84.23% | 84.23% | 83.15% | 256.53% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -51.31% | 84.23% | 84.23% | 83.15% | 256.53% |
|
|
|||||
| Total Common Equity | -44.64% | -26.33% | -15.98% | -9.44% | 24.14% |
| Total Preferred Equity | -51.31% | 84.23% | 84.23% | 83.15% | 256.53% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -48.15% | -0.59% | 3.88% | 7.12% | 88.91% |
|
|
|||||